Research
Hormonal
Probiotics can improve gut barrier integrity and reduce metabolic endotoxemia (LPS translocation) in obese models, thereby lowering systemic inflammation.
A healthy gut lining helps prevent inflammation, which is linked to obesity. Probiotics may help strengthen this barrier, but the most effective way to support gut health is through a diet rich in fiber and fermented foods.
ModerateSupportsMEDIUM confidence
Administration of Bifidobacteria to rodents with thermal injury improved gut integrity and metabolic endotoxemia [39]. ... VSL3 ... had a 60-fold increase in MUC 2 expression as well as an increased secretion of mucin [67].
Why this rating
Strong mechanistic evidence in animals, but human application is less clear.
Source
Probiotics: How Effective Are They in the Fight against Obesity?
Kiran Mazloom et al. · Nutrients · 2019
DOI 10.3390/nu11020258
narrative_reviewCited 188×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
- Obesity is associated with a specific gut microbiota composition characterized by a higher Firmicutes-to-Bacteroidetes ratio, lower bacterial gene richness, and increased gut permeability leading to metabolic endotoxemia.Good
- Administration of specific probiotic strains (primarily Lactobacillus and Bifidobacterium) reduces body weight and adipose tissue mass in diet-induced obese animal models through mechanisms involving SCFA production, gut barrier integrity, and immune modulation.Moderate
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →